Lotus Eye Hospit Share Price ₹115 | P/E 1480.4

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Lotus Eye Hospit

Quarter-by-quarter operating performance

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales +	11.17	12.57	12.73	12.03	10.88	12.89	12.91	12.25	11.51	13.52	13.04	13.55	13.61
Expenses +	9.78	10.18	10.92	10.45	10.12	11.23	11.76	11.46	11.68	12.04	12.27	12.89	13.13
Operating Profit	1.39	2.39	1.81	1.58	0.76	1.66	1.15	0.79	-0.17	1.48	0.77	0.66	0.48
OPM %	12.44%	19.01%	14.22%	13.13%	6.99%	12.88%	8.91%	6.45%	-1.48%	10.95%	5.90%	4.87%	3.53%
Other Income +	0.36	0.29	0.28	0.34	0.40	0.31	0.27	0.22	0.52	0.19	0.27	0.24	0.47
Interest	0.02	0.02	0.01	0.04	0.03	0.06	0.08	0.13	0.09	0.12	0.12	0.29	0.33
Depreciation	0.78	0.73	0.89	0.98	1.12	1.06	1.23	1.31	-0.58	0.82	0.85	0.98	1.10
Profit before tax	0.95	1.93	1.19	0.90	0.01	0.85	0.11	-0.43	0.84	0.73	0.07	-0.37	-0.48
Tax %	31.58%	27.98%	28.57%	26.67%	-200.00%	28.24%	9.09%	-44.19%	70.24%	24.66%	-71.43%	-29.73%	-33.33%
Net Profit +	0.65	1.38	0.85	0.66	0.02	0.62	0.10	-0.24	0.25	0.54	0.12	-0.26	-0.32
EPS in Rs	0.31	0.66	0.41	0.32	0.01	0.30	0.05	-0.12	0.12	0.26	0.06	-0.13	-0.15

Financials of Lotus Eye Hospit

Annual income statement trend

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Sales +	29.90	31.13	33.96	38.02	38.43	40.55	32.35	38.90	47.03	48.20	49.55	53.71
Expenses +	27.72	27.14	30.63	33.68	35.21	36.57	28.73	32.98	39.35	41.57	45.99	50.33
Operating Profit	2.18	3.99	3.33	4.34	3.22	3.98	3.62	5.92	7.68	6.63	3.56	3.38
OPM %	7.29%	12.82%	9.81%	11.42%	8.38%	9.82%	11.19%	15.22%	16.33%	13.76%	7.18%	6.29%
Other Income +	0.46	0.58	0.68	0.91	0.68	0.21	0.84	0.88	1.15	1.31	1.31	1.18
Interest	0.10	0.16	0.15	0.18	0.21	0.24	0.14	0.21	0.20	0.20	0.48	0.86
Depreciation	4.76	4.44	3.44	3.37	3.06	2.50	2.33	2.50	2.98	3.73	3.01	3.75
Profit before tax	-2.22	-0.03	0.42	1.70	0.63	1.45	1.99	4.09	5.65	4.01	1.38	-0.05
Tax %	-10.81%	-400.00%	-7.14%	-2.35%	-12.70%	26.90%	21.11%	27.14%	27.79%	27.43%	46.38%	-280.00%
Net Profit +	-1.98	0.10	0.44	1.75	0.71	1.06	1.57	2.98	4.08	2.91	0.74	0.08
EPS in Rs	-0.95	0.05	0.21	0.84	0.34	0.51	0.75	1.43	1.96	1.40	0.36	0.04
Dividend Payout %	0.00%	0.00%	236.36%	59.43%	0.00%	0.00%	66.24%	34.90%	25.49%	0.00%	0.00%	0.00%

Financials of Lotus Eye Hospit

Capital structure and asset base

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	20.80	20.80	20.80	20.80	20.80	20.80	20.80	20.80	20.80	20.80	20.80	20.80
Reserves	28.59	28.69	29.26	29.84	29.32	30.46	31.90	33.81	36.78	38.61	39.20	39.34
Borrowings +	0.83	0.66	0.48	0.29	0.22	0.32	0.40	1.24	0.67	1.11	3.43	15.83
Other Liabilities +	6.20	4.68	4.40	7.28	6.18	6.53	6.12	5.75	4.93	6.11	6.14	6.63
Total Liabilities	56.42	54.83	54.94	58.21	56.52	58.11	59.22	61.60	63.18	66.63	69.57	82.60
Fixed Assets +	47.04	43.57	41.32	42.52	44.14	42.67	40.54	44.07	44.18	48.65	54.07	65.81
CWIP	0.27	0.42	0.65	0.29	0.29	0.00	0.00	0.00	0.00	0.08	0.00	0.09
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets +	9.11	10.84	12.97	15.40	12.09	15.44	18.68	17.53	19.00	17.90	15.50	16.70
Total Assets	56.42	54.83	54.94	58.21	56.52	58.11	59.22	61.60	63.18	66.63	69.57	82.60

Financials of Lotus Eye Hospit

Operating, investing and financing cash movement

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity +	2.37	3.38	2.97	5.78	4.20	4.97	2.73	4.41	4.39	5.68	2.70	0.00
Cash from Investing Activity +	-4.65	-0.85	-1.06	-3.86	-4.01	-0.68	0.49	-3.94	-2.19	-4.63	-6.13	0.00
Cash from Financing Activity +	1.87	-0.58	-0.25	-1.51	-1.41	0.13	-0.32	-1.58	-1.71	-3.40	-1.60	0.00
Net Cash Flow	-0.40	1.96	1.66	0.41	-1.22	4.42	2.90	-1.10	0.49	-2.35	-5.03	0.00
Free Cash Flow	-2.38	2.28	1.55	1.58	-0.49	3.54	2.61	-0.25	1.30	0.10	-2.09	0.00
CFO/OP	109%	85%	92%	142%	134%	132%	84%	89%	76%	101%	94%	0%

Financials of Lotus Eye Hospit

Working capital efficiency and return ratios

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	4.27	5.98	7.31	10.94	7.22	5.94	8.35	5.82	9.08	9.54	9.72	8.22
Inventory Days	121.54	113.25	60.22	79.23	128.20	124.42	138.82	150.03	153.60	170.30	193.62	84.01
Days Payable	125.08	105.51	87.32	129.95	167.37	170.41	220.72	231.21	173.42	183.56	169.86	71.29
Cash Conversion Cycle	0.73	13.72	-19.79	-39.78	-31.95	-40.05	-73.54	-75.37	-10.74	-3.72	33.48	20.95
Working Capital Days	-19.90	-8.56	-8.92	-26.02	-15.39	-21.33	-23.92	-16.33	8.61	5.68	0.00	-12.23
ROCE %	-4.23%	0.24%	1.19%	3.63%	1.66%	4.67%	3.92%	7.91%	10.25%	7.07%	2.99%	1.16%

Manipal Health Enterprises Ltd (Q1 FY27)
Volume-led growth with inpatient (IP) volumes up 39% and outpatient (OP) volumes up 26% year-on-year. Key concall takeaways from Manipal Health Enterprises…
Fortis Healthcare Ltd (Q1 FY27)
IHH plans to increase its stake in Fortis to over 50% within 3-5 years, supporting long-term strategic growth. Key concall takeaways from Fortis Healthcare…
Metropolis Healthcare Ltd (Q1 FY27)
East India currently 6%, with limited investment so far; future investments may increase contribution. Key concall takeaways from Metropolis Healthcare Ltd's…
Apollo Hospitals Enterprise Ltd (Q1 FY27)
IP volume growth for established units guided at roughly 7% to 8%. Key concall takeaways from Apollo Hospitals Enterprise Ltd's Q1 FY27 earnings call — and how…

Lotus Eye Hospit Share Price & Earnings Call Analysis